Equity Research firms currently have a positive stance on shares of MGC Diagnostics Corporation (NASDAQ:MGCD). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.00. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $10.00 on a short term basis.
At the time of writing, the stock was trading at $7.13. This represents a change from the opening price of 0.00%. In terms of performance, year to date, the stock is 7.95%. The monthly stock performance comes in at 1.06%. For the quarter, shares are performing at 10.47%. Weekly performance analysis shows the equity at -0.49%.
In taking a look at technical levels, shares are trading 1.33% away from the 50 day simple moving average and 9.69% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -9.47% away from it’s 52- week high and 37.02% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, MGC Diagnostics Corporation’s RSI stands at 48.67. In looking at volatility levels, the shares saw weekly volatility of 4.54% and 4.45% over the past month.